JinkoSolar’s third-quarter shipments rose even more than August’s forecast, surging 55%, allowing the Chinese solar company to again boost the year’s guidance. American depositary shares rose 11% to $32.69 premarket.

Tyson’s fiscal fourth-quarter earnings rose as the company upped international food production in China and focused on growing its prepared foods business. Shares of the chicken-producer rose 3.9% to $29.88 premarket as results topped expectations and the company issued a fiscal year revenue forecast slightly above expectations.

AbbVie Inc. said that its oral treatment regimen for hepatitis C showed positive results in 96% of patients in the first of six phase III studies, putting the company on track to make regulatory submissions in the second quarter of next year.

Fund management group DIF agreed to acquire four new solar power plants from a Canadian Solar Inc. (CSIQ) subsidiary for an undisclosed sum.

General Electric Co. agreed to sell the so-called Vital Signs segment of its health-care operation to CareFusion Corp. (CFN) for $500 million.

J.P. Morgan Chase & Co. agreed to pay $4.5 billion to investors seeking to recover losses from mortgage-backed securities sold before the financial crisis, the latest attempt by the largest U.S. bank to put its legal woes behind it.

Towers Watson & Co.’s board authorized a roughly 22% increase to the consulting firm’s dividend. The company said Friday it will now pay a quarterly cash dividend of 14 cents per share, up from 11.5 cents a share previously.